Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3CNS 3Myeloid 2Lymphoid 2Genitourinary 2Sarcoma 1

Conditions

Sarcoma 189Osteosarcoma 72Sarcoma, Ewing 49Rhabdomyosarcoma 44Melanoma 40Neuroblastoma 35Gastrointestinal Stromal Tumors 34Neoplasms 32Colorectal Neoplasms 29Glioblastoma 28Bone Neoplasms 27Neoplasm Metastasis 26Ovarian Neoplasms 25Breast Neoplasms 25Wilms Tumor 22Gliosarcoma 22Glioma 22Rhabdoid Tumor 21Lymphoma, Non-Hodgkin 21Sarcoma, Kaposi 20Liposarcoma 20Carcinoma, Non-Small-Cell Lung 20Pancreatic Neoplasms 18Neurofibrosarcoma 18Medulloblastoma 18Hepatoblastoma 18Carcinoma, Renal Cell 18Lymphoma 17Thyroid Neoplasms 16Desmoid Tumors 16

Interventions

palbociclib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Familial ependymoma × Sarcoma × 90 days × Clear all
NCT03526250 2026-04-03

Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)

National Cancer Institute (NCI)

Phase 2 Completed
23 enrolled 11 charts
CNSGastrointestinalGenitourinaryLymphoidMyeloidSarcoma

Familial ependymoma, Ependymoma, Glioma, Histiocytosis, Langerhans-Cell, Lymphoma, Non-Hodgkin, Medulloblastoma, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡